Investors

Sign up for our Investors Newsletter and get early access to our latest product development and scientific research.


Some of our proud achievements:

01
US & EU Patent Approved 2018
02
Customer data integrity & security
03
Pioneers in high-throughput glycan analyse

Our numbers speak for themselves

€15M + EU research funding
120 + Scientific publications in leading journals
100k + People sample baseline from 30 different countries
40 + Scientists available to us from Genos

Our Collaborators

Sign up for our Investors Newsletter and get early access to our latest product development and scientific research.